Strategic Financial Concepts LLC Buys New Shares in Church & Dwight Co., Inc. (NYSE:CHD)

Strategic Financial Concepts LLC purchased a new stake in shares of Church & Dwight Co., Inc. (NYSE:CHD) in the 4th quarter, Holdings Channel reports. The fund purchased 39,162 shares of the company’s stock, valued at approximately $39,000.

A number of other hedge funds have also recently bought and sold shares of CHD. YANKCOM Partnership acquired a new stake in shares of Church & Dwight in the 4th quarter valued at approximately $25,000. Bleakley Financial Group LLC raised its position in Church & Dwight by 1.3% during the fourth quarter. Bleakley Financial Group LLC now owns 27,159 shares of the company’s stock worth $2,844,000 after acquiring an additional 346 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. lifted its stake in Church & Dwight by 29.6% in the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 34,662 shares of the company’s stock valued at $3,665,000 after acquiring an additional 7,913 shares during the last quarter. Weaver Capital Management LLC grew its position in shares of Church & Dwight by 3.3% in the 4th quarter. Weaver Capital Management LLC now owns 3,627 shares of the company’s stock valued at $380,000 after acquiring an additional 116 shares during the period. Finally, E. Ohman J or Asset Management AB increased its stake in shares of Church & Dwight by 13.3% during the 4th quarter. E. Ohman J or Asset Management AB now owns 11,100 shares of the company’s stock worth $1,162,000 after purchasing an additional 1,300 shares during the last quarter. 86.60% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on CHD. Stifel Nicolaus raised their target price on shares of Church & Dwight from $103.00 to $105.00 and gave the company a “hold” rating in a research note on Monday, February 3rd. TD Cowen lifted their target price on Church & Dwight from $114.00 to $117.00 and gave the stock a “buy” rating in a research note on Monday, November 4th. Barclays increased their price target on Church & Dwight from $90.00 to $93.00 and gave the company an “underweight” rating in a research note on Tuesday, February 4th. Piper Sandler reduced their price objective on shares of Church & Dwight from $128.00 to $126.00 and set an “overweight” rating for the company in a research report on Monday, February 3rd. Finally, Truist Financial increased their price objective on shares of Church & Dwight from $110.00 to $115.00 and gave the company a “buy” rating in a research report on Monday, February 3rd. Two research analysts have rated the stock with a sell rating, seven have issued a hold rating and eight have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $111.53.

Church & Dwight Price Performance

Shares of NYSE CHD opened at $105.98 on Thursday. The business has a fifty day moving average price of $105.63 and a two-hundred day moving average price of $104.45. The stock has a market capitalization of $25.97 billion, a PE ratio of 44.72, a P/E/G ratio of 3.35 and a beta of 0.59. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.70 and a quick ratio of 1.24. Church & Dwight Co., Inc. has a fifty-two week low of $96.09 and a fifty-two week high of $113.50.

Church & Dwight (NYSE:CHD) last posted its quarterly earnings data on Friday, January 31st. The company reported $0.77 earnings per share for the quarter, hitting the consensus estimate of $0.77. Church & Dwight had a net margin of 9.58% and a return on equity of 20.03%. During the same quarter in the previous year, the business earned $0.65 earnings per share. As a group, equities analysts predict that Church & Dwight Co., Inc. will post 3.7 earnings per share for the current fiscal year.

Church & Dwight Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, March 3rd. Shareholders of record on Friday, February 14th will be given a dividend of $0.295 per share. This is an increase from Church & Dwight’s previous quarterly dividend of $0.28. This represents a $1.18 annualized dividend and a yield of 1.11%. The ex-dividend date of this dividend is Friday, February 14th. Church & Dwight’s payout ratio is currently 47.68%.

Insiders Place Their Bets

In other Church & Dwight news, EVP Michael Read bought 1,100 shares of the stock in a transaction on Monday, December 16th. The stock was purchased at an average price of $106.82 per share, with a total value of $117,502.00. Following the completion of the purchase, the executive vice president now owns 2,505 shares in the company, valued at $267,584.10. The trade was a 78.29 % increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through the SEC website. Also, CAO Joseph James Longo sold 7,780 shares of the firm’s stock in a transaction that occurred on Friday, November 22nd. The shares were sold at an average price of $112.44, for a total transaction of $874,783.20. Following the completion of the sale, the chief accounting officer now owns 400 shares in the company, valued at approximately $44,976. The trade was a 95.11 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 102,422 shares of company stock worth $11,424,351 over the last three months. Insiders own 2.00% of the company’s stock.

About Church & Dwight

Church & Dwight Co, Inc engages in the development, manufacture, and marketing of household, personal care, and specialty products. It operates through the following segments: Consumer Domestic, Consumer International, Specialty Products, and Corporate. The Consumer Domestic segment offers household products, such as laundry detergents, fabric softener sheets, cat litter, and household cleaning products, and personal care products including antiperspirants, oral care products, depilatories, reproductive health products, oral analgesics, nasal saline moisturizers, and dietary supplements.